Marcus Kremer

Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota

Bärbel Stecher, Riccardo Robbiani, Alan W. Walker et al. · PLoS Biology · 2007 · 1K citations · Full text

Pretreatment of Mice with Streptomycin Provides a<i>Salmonella enterica</i>Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host

Manja Barthel, Siegfried Hapfelmeier, Leticia Quintanilla-Martı́nez et al. · Infection and Immunity · 2003 · 1K citations · Full text

Extramedullary plasmacytoma

Christoph Alexiou, Reinhardt J. Kau, Hermann Dietzfelbinger et al. · Cancer · 1999 · 561 citations · Full text

The Salmonella Pathogenicity Island (SPI)-2 and SPI-1 Type III Secretion Systems Allow <i>Salmonella</i> Serovar <i>typhimurium</i> to Trigger Colitis via MyD88-Dependent and MyD88-Independent Mechanisms

Siegfried Hapfelmeier, Bärbel Stecher, Manja Barthel et al. · The Journal of Immunology · 2005 · 388 citations · Full text

Targeting cancer cells: magnetic nanoparticles as drug carriers

Christoph Alexiou, Roswitha J. Schmid, Roland Jurgons et al. · European Biophysics Journal · 2006 · 357 citations

Nanoparticles, Nanomedicine, Magnetic Nanoparticles +6